| Dr Patricia M Ingalls, AUD | |
|
1369 Harrison Ave, Suite C, Butte, MT 59701-4875 | |
| (406) 723-6600 | |
| (406) 723-6660 |
| Full Name | Dr Patricia M Ingalls |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 1369 Harrison Ave, Butte, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790865889 | NPI | - | NPPES |
| 0530374 | Medicaid | MT | |
| 029028 | Other | MT | BLUECROSS BLUESHIELD |
| 0151151 | Other | WA | WASH LABOR & INDUSTRY |
| 0569400 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 248 (Montana) | Primary |
| 237600000X | Audiologist-hearing Aid Fitter | 141 (Montana) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patricia M Ingalls, AUD 1369 Harrison Ave, Suite C, Butte, MT 59701-4875 Ph: (406) 723-6600 | Dr Patricia M Ingalls, AUD 1369 Harrison Ave, Suite C, Butte, MT 59701-4875 Ph: (406) 723-6600 |
News Archive
Nutrinia, developing therapies to treat rare gastrointestinal disorders, announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for the company's orally-administered drug for treating short bowel syndrome (SBS) in patients of all ages. Nutrinia plans to begin a pivotal clinical trial in this indication.
Plackers, makers of the first disposable dental flosser, and Oral Health America (OHA), a national, charitable non-profit, announced five winners of the first-ever Smiles Across America Innovation Grants, each of whom will receive monetary grants to kick-start innovative new programs intended to deliver oral health preventative products and services to children at increased risk for oral diseases.
Researchers in the United States have identified both antigen-specific and antigen non-specific predictive signatures of antibody responses to Moderna's two-dose coronavirus disease 2019 (COVID-19) vaccine that protects against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Treatment with a second-generation tyrosine kinase inhibitor prevents progression to blast crisis in chronic myeloid leukaemia patients with high levels of cancerous inhibitor of PP2A, research suggests.
Now, a team of researchers revealed another atypical symptom reported by patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19) – persistent hiccups.
› Verified 4 days ago
Dr. Susan Leigh Kalarchik, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 3310 Monroe Ave, Butte, MT 59701 Phone: 406-494-3995 Fax: 406-494-3373 | |
Bc Hearing Audiologist Medicare: Medicare Enrolled Practice Location: 3310 Monroe Ave, Suite 4, Butte, MT 59701 Phone: 406-494-3995 Fax: 406-494-3373 |